Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Study indicates potential of KRN-5500 in the treatment of leukemia and lymphoma

June 3, 1999

U. of Alberta designs new bis-benzimidazole anticancer agents

June 3, 1999

Academic investigators describe new agent for BNCT

June 3, 1999

Merck researchers discover nonpeptide GnRH antagonist series

June 3, 1999

Suppression of NF-kappaB enhances antitumor activity of TNF-alpha and CPT-11 via increased apoptosis

June 3, 1999

Oncolytics Biotech enters reovirus development agreement

June 3, 1999

Mitsubishi Chemical group describes inhibitors of EGF TK and tumor cell proliferation

June 2, 1999

Licensing opportunity from Fox Chase Cancer Center: MDR-reversing agents

June 2, 1999

Bavarian Nordic's tyrosinase vector enters safety study in Germany

June 2, 1999

Radiolabeled somatostatin analogue with potential for PET imaging and targeted radiotherapy

June 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...